Blue Ledge Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Halominehalomine.cominJun 2023 · $2.9M
AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris.
BiotechHealthtechNew Materials
Co-investorsRed Bear AngelsSOSV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.